<  Back to the Polytechnique Montréal portal

HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study

Francesca Carlino, Anna Diana, Anna Ventriglia, Antonio Piccolo, Carmela Mocerino, Ferdinando Riccardi, Domenico Bilancia, Francesco Giotta, Giuliano Antoniol, Vincenzo Famiglietti, Salvatore Feliciano, Rodolfo Cangiano, Lorenzo Lobianco, Benedetta Pellegrino, Ferdinando De Vita, Fortunato Ciardiello and Michele Orditura

Article (2022)

An external link is available for this item
Department: Department of Computer Engineering and Software Engineering
PolyPublie URL: https://publications.polymtl.ca/51857/
Journal Title: Cancers (vol. 14, no. 20)
Publisher: MDPI
DOI: 10.3390/cancers14204981
Official URL: https://doi.org/10.3390/cancers14204981
Date Deposited: 18 Apr 2023 14:58
Last Modified: 25 Sep 2024 16:42
Cite in APA 7: Carlino, F., Diana, A., Ventriglia, A., Piccolo, A., Mocerino, C., Riccardi, F., Bilancia, D., Giotta, F., Antoniol, G., Famiglietti, V., Feliciano, S., Cangiano, R., Lobianco, L., Pellegrino, B., De Vita, F., Ciardiello, F., & Orditura, M. (2022). HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study. Cancers, 14(20), 4981 (11 pages). https://doi.org/10.3390/cancers14204981

Statistics

Dimensions

Repository Staff Only

View Item View Item